Palisade Bio
(NASDAQ) PALI
Palisade Bio Financials at a Glance
Market Cap
$296.52M
Revenue (TTM)
$0.00
Net Income (TTM)
$11.23M
EPS (TTM)
$-4.22
P/E Ratio
-0.47
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$2.00
Volume
10
Open
$1.90
Price
$2.00
Volume
10
Open
$1.90
Previous Close
$1.99
Daily Range
$1.86 - $2.02
52-Week Range
$0.53 - $2.64
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$2.00
Volume
10
Open
$1.90
Previous Close
$1.99
Daily Range
$1.86 - $2.02
52-Week Range
$0.53 - $2.64
PALI News
PALI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Palisade Bio
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
J. D. Finley
Website
www.palisadebio.comHeadquarters
Carlsbad, CA 92008, US
PALI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-229%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
-2.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$296.52M
Shares Outstanding
149.00M
Volume
10
Short Interest
0.00%
Avg. Volume
4.49M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$14.86M
EBITDA
$14.42M
Operating Cash Flow
$12.19M
Capital Expenditure
$0.00
Free Cash Flow
$12.19M
Cash & ST Invst.
$9.82M
Total Debt
$169.00K
Palisade Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$296.52M
N/A
Market Cap/Employee
$37.06M
N/A
Employees
8
N/A
Net Income
$2.87M
+17.8%
EBITDA
$2.86M
+17.8%
Quarterly Fundamentals
Net Cash
$5.02M
-34.7%
Accounts Receivable
$18.00K
-81.3%
Inventory
$0.00
+100.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$211.00K
-40.9%
Return on Assets
-1.61%
N/A
Return on Invested Capital
-3.28%
N/A
Free Cash Flow
$3.55M
-13.4%
Operating Cash Flow
$3.55M
-13.4%